About Salvia BioElectronics
Salvia BioElectronics is a company based in Eindhoven (Netherlands) founded in 2017 by Wim Pollet.. Salvia BioElectronics has raised $88.4 million across 5 funding rounds from investors including Jazz Pharmaceuticals, Imec and Rijksdienst voor Ondernemend Nederland. Salvia BioElectronics offers products and services including Migraine Implant and Bioelectronic Therapy. Salvia BioElectronics operates in a competitive market with competitors including ElectroCore, ShiraTronics, eNeura, Cefaly and Zosano Pharma, among others.
- Headquarter Eindhoven, Netherlands
- Founders Wim Pollet
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Salvia Bioelectronics B.V.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$88.4 M (USD)
in 5 rounds
-
Latest Funding Round
$60 M (USD), Series B
May 27, 2025
-
Investors
Jazz Pharmaceuticals
& 12 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Salvia BioElectronics
Salvia BioElectronics offers a comprehensive portfolio of products and services, including Migraine Implant and Bioelectronic Therapy. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Implantable solution for treating chronic migraine in clinical studies.
Personalized device for neurological disorder management.
Funding Insights of Salvia BioElectronics
Salvia BioElectronics has successfully raised a total of $88.4M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $60 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $60.0M
-
First Round
First Round
(22 May 2018)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Series B - Salvia BioElectronics | Valuation | Innovation Industries | |
| Sep, 2020 | Amount | Series A - Salvia BioElectronics | Valuation | Panakes Partners , SHS | |
| Sep, 2020 | Amount | Debt – Conventional - Salvia BioElectronics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Salvia BioElectronics
Salvia BioElectronics has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Jazz Pharmaceuticals, Imec and Rijksdienst voor Ondernemend Nederland. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Healthcare-focused private equity investments are managed by SHS Capital.
|
Founded Year | Domain | Location | |
|
Investments are directed by BOM toward early and growth-stage firms.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Salvia BioElectronics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Salvia BioElectronics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Salvia Bioelectronics Comparisons
Competitors of Salvia BioElectronics
Salvia BioElectronics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ElectroCore, ShiraTronics, eNeura, Cefaly and Zosano Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Non-invasive vagus nerve stimulation devices are developed for headache treatments.
|
|
| domain | founded_year | HQ Location |
Neuromodulation devices for migraine and chronic disease treatment are developed.
|
|
| domain | founded_year | HQ Location |
Transcranial magnetic stimulation devices for migraine treatment are developed.
|
|
| domain | founded_year | HQ Location |
Neurostimulation devices for migraine and headache treatment are provided.
|
|
| domain | founded_year | HQ Location |
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Salvia Bioelectronics
Frequently Asked Questions about Salvia BioElectronics
When was Salvia BioElectronics founded?
Salvia BioElectronics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Salvia BioElectronics located?
Salvia BioElectronics is headquartered in Eindhoven, Netherlands. It is registered at Eindhoven, Noord-brabant, Netherlands.
Is Salvia BioElectronics a funded company?
Salvia BioElectronics is a funded company, having raised a total of $88.4M across 5 funding rounds to date. The company's 1st funding round was a Series A of $24.77M, raised on May 22, 2018.
What does Salvia BioElectronics do?
Salvia BioElectronics was founded in 2017 in Eindhoven, Netherlands, within the bioelectronics sector. Neuromodulation therapies are developed to address migraines and other neurological conditions. A thin implant has been created to deliver electrical pulses to relevant nerves, with the goal of reducing migraine frequency and severity. Operations focus on enhancing patient outcomes through targeted bioelectronic interventions in the European market.
Who are the top competitors of Salvia BioElectronics?
Salvia BioElectronics's top competitors include ShiraTronics, ElectroCore and eNeura.
What products or services does Salvia BioElectronics offer?
Salvia BioElectronics offers Migraine Implant and Bioelectronic Therapy.
Who are Salvia BioElectronics's investors?
Salvia BioElectronics has 13 investors. Key investors include Jazz Pharmaceuticals, Imec, Rijksdienst voor Ondernemend Nederland, European Union, and BOM.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.